Researchers have made a significant breakthrough in developing a new gene therapy approach that restores full-length dystrophin protein, which could lead to new treatments for people with Duchenne muscular dystrophy (DMD).
Categories
Recent Posts
- What to Know Before You Start Adaptive Driving
- FDA names once-daily (Z)-endoxifen an orphan drug for Duchenne
- Capricor provides regulatory update on Deramiocel for Duchenne
- Guest Voice: Pushing for access to Duchenne clinical trials in Malaysia
- People have told me I’m a strong person, but what is strength?
Archive
- January 2026
- December 2025
- November 2025
- October 2025
- September 2025
- August 2025
- July 2025
- June 2025
- May 2025
- April 2025
- March 2025
- February 2025
- January 2025
- December 2024
- November 2024
- October 2024
- September 2024
- August 2024
- July 2024
- June 2024
- May 2024
- April 2024
- March 2024
- February 2024
- January 2024
